Towards in vitro models for reducing or replacing the use of animals in drug testing
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early model developers have growing demands for these reference lists and can use them to benchmark their models against existing in vivo data, whether from animal models or human subjects (Stresser et al., 2024).”
From Considering future qualification for regulatory science in the early development of microphysiological systems: a case study of microthrombosis in a Vessel-on-Chip (2024) · cites this paper as Stresser et al., 2024
Citations
Cites
Human organs-on-chips for disease modelling, drug development and personalized medicine
Ingber, D. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00466-9 · Cited by 1,589
Organs-on-chips: into the next decade
Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P., & Tagle, D. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0079-3 · Cited by 1,029
A multi-organ chip with matured tissue niches linked by vascular flow
Ronaldson-Bouchard, K., Teles, D., Yeager, K., Tavakol, D. N., Zhao, Y., Chramiec, A., Tagore, S., Summers, M., Stylianos, S., Tamargo, M., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00882-6 · Cited by 512
Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies
Edington, C. D., Chen, W. L. K., Geishecker, E., Kassis, T., Soenksen, L. R., Bhushan, B. M., Freake, D., Kirschner, J., Maass, C., Tsamandouras, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22749-0 · Cited by 487
Self-citationMulti-Organ toxicity demonstration in a functional human in vitro system composed of four organs
Oleaga, C., Bernabini, C., Smith, A. S. T., Srinivasan, B., Jackson, M., McLamb, W., Platt, V., Bridges, R., Cai, Y., Santhanam, N., et al. (2016) · Scientific Reports · doi:10.1038/srep20030 · Cited by 442
Robotic fluidic coupling and interrogation of multiple vascularized organ chips
Novak, R., Ingram, M., Marquez, S., Das, D., Delahanty, A., Herland, A., Maoz, B. M., Jeanty, S. S. F., Somayaji, M. R., Burt, M., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0497-x · Cited by 427
New approach methodologies in human regulatory toxicology – Not if, but how and when!
Schmeisser, S., Miccoli, A., von Bergen, M., Berggren, E., Braeuning, A., Busch, W., Desaintes, C., Gourmelon, A., Grafström, R., Harrill, J., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108082 · Cited by 380
Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology
Ewart, L., Apostolou, A., Briggs, S. A., Carman, C. V., Chaff, J. T., Heng, A. R., Jadalannagari, S., Janardhanan, J., Jang, K.-J., Joshipura, S. R., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00209-1 · Cited by 337
Self-citationUtility of spherical human liver microtissues for prediction of clinical drug-induced liver injury
Proctor, W. R., Foster, A. J., Vogt, J., Summers, C., Middleton, B., Pilling, M. A., Shienson, D., Kijanska, M., Ströbel, S., Kelm, J. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2002-1 · Cited by 328
Marx, U. (2020) · ALTEX · doi:10.14573/altex.2001241 · Cited by 218
Self-citation
Research works printed but not linked: 10
- OECD Test Guidelines for Chemicals (OECD, accessed 24 October 2023); https://go.nature.com/3T4GMeV
- Baran, S. W. et al. ALTEX 39, 297–314 (2022).
- Marx, U. et al. ALTEX 37, 365–394 (2020).
- OTP INTERACT Meeting (FDA, 14 June 2023); https://go.nature.com/47S08bq
- PDUFA Reauthorization Performance Goals and Procedures Fiscal Years 2023 Through 2027 (FDA, 2022); https://go.nature.com/413kiwP
- Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program (FDA, 6 April 2023); https://go.nature.com/418CsNq
- Irrechukwu, O. et al. ALTEX 40, 485–518 (2023).
- Ramsden, D. et al. ALTEX 39, 273–296 (2022).
- Wang, X. et al. ALTEX 40, 314–336 (2022).
- Medina, L. V., Coenen, J. & Kastello, M. D. J. Am. Assoc. Lab Anim. Sci. 54, 115–118 (2015).
Cited by
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
Wang, D., Villenave, R., Stokar‐Regenscheit, N., & Clevers, H. C. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01317-y · Cited by 129
Self-citationOrganoid bioprinting: from cells to functional tissues
Huang, M. S., Christakopoulos, F., Roth, J. G., & Heilshorn, S. C. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00268-0 · Cited by 114
“The US Food and Drug Administration (FDA) Modernization Act 2.0 expanded the role for new approach methodologies to reduce or replace in vivo studies in drug applications to the FDA and highlights the potential use of organoids as platforms for drug screens 186 .”
InfluentialDu, Y., Wang, Y., Bao, Q., Xu, X., Xu, C., Wang, S., Liu, Q., Liu, F., Zeng, Y., Wang, Y., et al. (2024) · Advanced Materials · doi:10.1002/adma.202412815 · Cited by 111
Microfluidic high-throughput 3D cell culture
Ko, J., Park, D., Lee, J., Jung, S., Baek, K., Sung, K. E., Lee, J., & Jeon, N. L. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00163-8 · Cited by 88
“Such systems may be particularly useful for non-clinical drug testing, as supported by the FDA Modernization Act 2.0, which aims at reducing the use of animals in non-clinical testing if scientifically reliable in vitro models are available 10 .”
InfluentialLin, C., Huang, X. L., Xue, Y., Jiang, S., Chen, C., Liu, Y., & Chen, K. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.02.017 · Cited by 86
“Their integration with regulatory frameworks is expected to gradually take shape [118,119].”
Metadata
- Authors
- Stresser, D. M., Kopec, A. K., Hewitt, P., Hardwick, R. N., Van Vleet, T. R., Mahalingaiah, P. K. S., O’Connell, D., Jenkins, G. J., David, R., Graham, J., Lee, D., Ekert, J., Fullerton, A., Villenave, R., Bajaj, P., Gosset, J. R., Ralston, S. L., Guha, M., Amador-Arjona, A., Khan, K., Agarwal, S., Hasselgren, C., Wang, X., Adams, K., Kaushik, G., Raczynski, A., & Homan, K. A.
- Affiliations
- AbbVie (United States) (US)
- Pfizer (United States) (US)
- Merck KGaA, Darmstadt (Germany) (DE)
- Bristol-Myers Squibb (United States) (US)
- AstraZeneca (United Kingdom) (GB)
- Genentech (US)
- Sanofi (United States) (US)
- Incyte (United States) (US)
- Alnylam Pharmaceuticals (United States) (US)
- Amgen (United States) (US)
- Boehringer Ingelheim (United States) (US)
- Vertex Pharmaceuticals (United States) (US)
- Corresponding author
- Stresser, David M.
- Homan, Kimberly A.
- ORCID
- Stresser, David M.
- Kopec, Anna K.
- Hewitt, Philip
- Hardwick, Rhiannon N.
- Van Vleet, Terry R.
- Mahalingaiah, Prathap Kumar S.
- Jenkins, Gary J.
- David, Rhiannon
- Graham, Jessica
- Lee, Donna
- Ekert, Jason
- Fullerton, Aaron
- Villenave, Remi
- Bajaj, Piyush
- Ralston, Sherry L.
- Guha, Manti
- Khan, Kainat
- Agarwal, Saket
- Wang, Xiaoting
- Kaushik, Gaurav
- Homan, Kimberly A.
- Venue
- Nature Biomedical Engineering
- Published
- 2023-12-27
- Volume
- 8
- Issue
- 8
- Pages
- 930-935
- ISSN
- 2157-846X (ISSN-L)
- OpenAlex
- W4390273685
- Cited by
- 94
- References
- 61
- Citations by year
- 2026: 25 · 2025: 37 · 2024: 31 · 2023: 1
- FWCI
- 28.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- in vitro model, animal use reduction, 3Rs, drug discovery, drug development, alternatives to animal testing
- MeSH terms
- Animals, Animal Testing Alternatives, Drug Evaluation, Preclinical, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Towards in vitro models for reducing or replacing the use of animals in drug testing. https://app.cochat.ai/papers/10.1038/s41551-023-01154-7
- The paper
- Stresser, D. M., Kopec, A. K., Hewitt, P., Hardwick, R. N., Van Vleet, T. R., Mahalingaiah, P. K. S., O’Connell, D., Jenkins, G. J., David, R., Graham, J., Lee, D., Ekert, J., Fullerton, A., Villenave, R., Bajaj, P., Gosset, J. R., Ralston, S. L., Guha, M., Amador-Arjona, A., . . . Homan, K. A. (2023). Towards in vitro models for reducing or replacing the use of animals in drug testing. Nature Biomedical Engineering. https://doi.org/10.1038/s41551-023-01154-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.